Evaluation of the Pharmacokinetic Interaction of Ubrogepant Coadministered With Sumatriptan and of the Safety of Ubrogepant With Triptans

OBJECTIVE: To evaluate the potential for pharmacokinetic interaction and the safety and tolerability when ubrogepant and sumatriptan are coadministered in a Phase 1 study in healthy participants, and to inform the safety and tolerability of ubrogepant alone and in combination with triptans in Phase...

Descripción completa

Detalles Bibliográficos
Autores principales: Jakate, Abhijeet, Boinpally, Ramesh, Butler, Matthew, Lu, Kaifeng, McGeeney, Danielle, Periclou, Antonia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Research Submissions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7496299/
https://www.ncbi.nlm.nih.gov/pubmed/32573795
http://dx.doi.org/10.1111/head.13862

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7496299/
https://www.ncbi.nlm.nih.gov/pubmed/32573795
http://dx.doi.org/10.1111/head.13862

Ejemplares similares